News Formal

SA finalising R25m investment to boost pan-African vaccine manufacturing capabilities

  • 📰 TheCitizen_News
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 75%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

The SA Medical Research Council and the department of science and innovation have provided R10 million funding for the first South African Covid-19 vaccine trial.

South Africa is in the process of finalising a R25 million investment to boost pan-African Covid-19 vaccine manufacturing capabilities.

“We are currently in the process of finalising a R25 million investment to boost pan-African vaccine manufacturing capabilities through the African Renaissance Fund.” “As the international community, we have been unanimous that services, supplies, products and technologies for prevention, treatment and care of COVID-19 must be available to all. No country must be left behind.”

“One looks for instance at the advances in ventilator development and production in developing countries.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 6. in SE

Sverige Senaste nytt, Sverige Rubriker